Phase I study of tomuzotuximab, a glycoengineered therapeutic antibody against the epidermal growth factor receptor, in patients with advanced carcinomas - Fiedler, Walter; Cresta, Sara; Schulze-Bergkamen, Henning; Dosso, Sara De; Weidmann, Jens; Tessari, Anna; Baumeister, Hans; Danielczyk, Antje; Dietrich, Bruno; Goletz, Steffen; Zurlo, Alfredo; Salzberg, Marc; et al. (ESMO open, 2018)
Gesehen am 17.04.2020